Status:
WITHDRAWN
Multi-cancer Joint Screening and Early Diagnosis and Treatment Project Based on the Combination of Chinese Traditional and Western Medicine in Lanxi City
Lead Sponsor:
Lanxi Hospital of Traditional Chinese Medicine
Collaborating Sponsors:
Zhejiang Chinese Medical University
Zhejiang Cancer Hospital
Conditions:
Cancer Screening
Eligibility:
All Genders
45-74 years
Brief Summary
This study conducted a joint screening and early diagnosis and recommended treatment for LCA, LC, UGIC, and CRC among residents aged 45 to 74 in six townships of Lanxi City, Zhejiang Province. Residen...
Detailed Description
Screening Methods Population Selection for Screening: Utilizing a cluster sampling approach, one-fifth of the residents from six townships/districts were selected as the target population. Villages (c...
Eligibility Criteria
Inclusion
- The survey focused on residents aged 45 to 74 years, based on their permanent residency status (The date of birth on the ID card shall prevail).
- All participants possessed full legal capacity and voluntarily signed informed consent forms.
Exclusion
- Individuals who had moved out, long-term absence, or had household separation were excluded. The screening participants were further confirmed to meet the eligibility criteria after excluding those with poor compliance, already diagnosed with tumors, or having severe heart, brain, lung diseases, or renal dysfunction.
Key Trial Info
Start Date :
May 12 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 5 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06200051
Start Date
May 12 2023
End Date
May 5 2024
Last Update
July 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jing Xiao
Lanxi, Zhejiang, China, 321100